Literature DB >> 12798499

Secretion of 6beta-hydroxycortisol by normal human adrenals and adrenocortical adenomas.

Nikolette Szucs1, Ibolya Varga, Attila Patócs, Miklós Tóth, Edit Gláz, Károly Rácz.   

Abstract

Although 6beta-hydroxycortisol (6betaOHF) is usually considered a cortisol metabolite produced by the liver, a few reports suggest that it may also originate from extrahepatic sources. To examine whether human adrenal cells are capable of 6beta-hydroxylating cortisol, we measured 6betaOHF secretion with a radioimmunoassay method in isolated human adrenal cell systems obtained from three normal adrenals, four nonhyperfunctioning adrenocortical adenomas, two adrenal adenomas causing Cushing's syndrome, and five aldosterone (Aldo)-producing adenomas. Cells were examined both under basal conditions and after stimulation with adrenocorticotrophic hormone (ACTH). In addition, 6betaOHF concentrations were determined in inferior vena cava and suprarenal vein plasma samples obtained from the side of nonhyperfunctioning adrenal adenomas (five patients) and aldosterone-producing adenomas (five patients). Under basal incubation conditions, 6betaOHF secretion, expressed as a percent of cortisol secretion, was between 0.5 and 2.0% in normal adrenal cells, between 1.0 and 7% in cells from nonhyperfunctioning adenomas, 12 and 15% in cells from Cushing's syndrome patients, and between 2.6 and 3.9% in cells from aldosterone-producing adenomas. In these cells, increasing doses of ACTH produced a dose-dependent stimulation of both 6betaOHF and cortisol secretion. The 6betaOHF concentration in suprarenal vein samples obtained from the side of adenomas was markedly increased; the suprarenal vein/inferior vena cava 6betaOHF ratios were 13.1+/-2.1 (mean+/-S.E.) in the case of nonhyperfunctioning adenomas and 17.8+/-4.5 in the case of aldosterone-producing adenomas. These results firmly suggest that 6betaOHF is not only a hepatic metabolite, but also a secretory product of human adrenals and that similarly to cortisol, its secretion may be controlled by ACTH.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12798499     DOI: 10.1016/s0039-128x(03)00050-3

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  3 in total

1.  Canine urinary lactate and cortisol metabolites in hypercortisolism, nonadrenal disease, congestive heart failure, and health.

Authors:  Arnon Gal; Ryan Fries; Saki Kadotani; Alexander V Ulanov; Zhong Li; J Catharine Scott-Moncrieff; Richard K Burchell; Nicolas Lopez-Villalobos; Yigal Petreanu
Journal:  J Vet Diagn Invest       Date:  2022-06-03       Impact factor: 1.569

2.  Evaluation of CYP3A activity in humans using three different parameters based on endogenous cortisol metabolism.

Authors:  Xi Luo; Xiao-min Li; Zhe-yi Hu; Ze-neng Cheng
Journal:  Acta Pharmacol Sin       Date:  2009-08-24       Impact factor: 6.150

3.  Cortisol and 11 beta-hydroxysteroid dehydrogenase type 2 as potential determinants of renal citrate excretion in healthy children.

Authors:  Yifan Hua; Jonas Esche; Michaela F Hartmann; Christiane Maser-Gluth; Stefan A Wudy; Thomas Remer
Journal:  Endocrine       Date:  2019-12-07       Impact factor: 3.633

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.